Option chain shows key data for Achari Ventures Holdings Corp I Ordinary Shares's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Achari Ventures Holdings Corp I Ordinary Shares.

Achari Ventures Holdings Corp I Ordinary Shares (OTC:AVHI) Stock, Option Chain

Achari Ventures Hldgs

News

Movers & Shakers

Pre-Market Outlook

Markets

Movers

Trading Ideas

AAPL

AAXN

ADXS

AMSC

AVHI

AXON

AZRX

CLDR

CLWT

CONN

CYTX

DCPH

EOLS

FIVE

FSLR

GSHD

HEAR

IFON

MDGL

MDLY

MDXG

MESO

MRTX

NKTR

OPHT

PACB

PAGS

REVG

RRTS

RSLS

SNES

SNSS

SONC

SSTI

TMHC

TOPS

UNFI

VBLT

45 Biggest Movers From Yesterday

Eurozone

Commodities

Global

Intraday Update

Mid-Afternoon Market Update: NASDAQ Down Over 1%; AV Homes Shares Spike Higher

ATHX

CWBR

DFIN

ICHR

MEIP

UONE

36 Stocks Moving In Thursday&#39;s Mid-Day Session

Achari Ventures Holdings Corp I Ordinary Shares

Achari Ventures Holdings Corp I Units (1 Ord Share & 1 War)

Achari Ventures Holdings Corp I Warrants (01/01/2026)

Achari Ventures Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVHI#NASDAQ">AVHI</a>) reported quarterly losses of $(0.13) per share. This is a 1200 percent decrease over losses of $(0.01) per share from the same period last year.

Earnings

Achari Ventures Hldgs Q4 EPS $(0.13) Down From $(0.01) YoY

VASO

Medical Technology Company Vaso, Currently Trading On OTC Market, To List On Nasdaq Via SPAC Merger; Transaction Values Vaso At Pro Forma Equity Value Of $176M At $10 Per Share

Achari Ventures Holdings Corp I: Said On Oct 5, Received Letter From Staff At Nasdaq Stating Co Has Not Regained Compliance With MVLS Requirement

Achari Ventures Holdings Corp. I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVHI#NASDAQ">AVHI</a>) (the &quot;Company&quot; or &quot;Achari&quot;) today announced that as it had previously disclosed, the Company received a deficiency letter on&nbsp;May 23, 2023&nbsp;from the Listing Qualifications Department of The NASDAQ Stock Market LLC (&quot;Nasdaq&quot;), stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), as a result of the Company&#39;s delay in filing its Form 10-Q for the period ending March 31, 2023 (the &quot;Form 10-Q&quot;) with the Securities and Exchange Commission (the &quot;SEC&quot;).
On&nbsp;May 26, 2023, the Company filed its Form&nbsp;10-Q&nbsp;for the period ended&nbsp;March 31, 2023&nbsp;with the SEC.

Achari Ventures Holdings Corp. I Announces Receipt Of NASDAQ Continued Listing Standard Notice

IPOs

Achari Ventures Holdings Corp. I  Shares Will Open For Quote At 11 a.m. EDT, Expected To Open For Trade After 11:10 a.m. EDT; IPO Priced $10/Unit

A V Homes (NASDAQ:<a class="ticker" href="/stock/AVHI#NASDAQ">AVHI</a>) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.22 by 40.91 percent. This is a 27.78 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $203.6 million which missed the analyst consensus estimate of $232.52 million by 12.44 percent. This is a 1.20 percent increase over sales of $201.194 million the same period last year.

A V Homes Q2 EPS $0.13 Misses $0.22 Estimate, Sales $203.6M Miss $232.52M Estimate

<h3>
	Gainers</h3>
<ul>
<li>
		Top Ships Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tops#NASDAQ">TOPS</a>) shares jumped 53.25 percent to close at $1.18 on Thursday after the company reported a time charter with a major oil company for its two Suezmax vessels.</li>
<li>
		AV Homes, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avhi#NASDAQ">AVHI</a>) shares gained 28.79 percent to close at $21.25 after Taylor Morrison Home Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tmhc#NYSE">TMHC</a>) agreed to acquire AV Homes at $21.50 per share in cash and stock.</li>
<li>
		Conn&#39;s Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/conn#NASDAQ">CONN</a>) jumped 24.56 percent to close at $31.95 on Thursday after the company reported better-than-expected results for its first quarter on Thursday.</li>
<li>
		Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>) gained 23.3 percent to close at $37.79 after reporting a third-quarter earnings and sales beat. The company issued strong fourth-quarter and fiscal 2018 earnings and sales guidance.</li>
<li>
		Five Below, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/five#NASDAQ">FIVE</a>) surged 21.86 percent to close at $99.05 after the company reported better-than-expected results for its first quarter The company also issued strong second quarter and fiscal 2018 earnings and sales guidance.</li>
<li>
		Turtle Beach Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hear#NASDAQ">HEAR</a>) rose 20.96 percent to close at $21.53.</li>
<li>
		Coffee Holding Co., Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jva#NASDAQ">JVA</a>) gained 18.53 percent to close at $4.99 following Q2 beat.</li>
<li>
		Mirati Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrtx#NASDAQ">MRTX</a>) jumped 18.4 percent to close at $46.00. Mirati Therapeutics priced its 2.75 million share common stock offering at $38.85 per share.</li>
<li>
		Sonic Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sonc#NASDAQ">SONC</a>) jumped 16.42 percent to close at $30.98. Sonic reiterated its FY18 outlook and increased its share repurchase authorization from $160 million to $500 million.</li>
<li>
		Roadrunner Transportation Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rrts#NASDAQ">RRTS</a>) gained 15.5 percent to close at $2.31.</li>
<li>
		Vishay Intertechnology, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vsh#NYSE">VSH</a>) rose 13.3 percent to close at $24.70 after reporting a proposed offering of $525 million of convertible senior notes.</li>
<li>
		ShotSpotter, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssti#NASDAQ">SSTI</a>) gained 11.8 percent to close at $36.37. JMP Securities initiated coverage on ShotSpotter with a Market Outperform rating.</li>
<li>
		Advaxis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adxs#NASDAQ">ADXS</a>) gained 11.11 percent to close at $1.90 following Q2 results.</li>
<li>
		Pacific Biosciences of California, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pacb#NASDAQ">PACB</a>) rose 11.03 percent to close at $3.02.</li>
<li>
		Euro Tech Holdings Company Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clwt#NASDAQ">CLWT</a>) gained 11.01 percent to close at $6.05 on Thursday.</li>
<li>
		ABM Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>) jumped 10.97 percent to close at $32.18 after reporting upbeat results for its fiscal third quarter.</li>
<li>
		Ophthotech Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opht#NASDAQ">OPHT</a>) shares gained 10.36 percent to close at $3.09 after the company disclosed that it has entered into gene therapy agreements with University of Florida and University of Pennsylvania.</li>
<li>
		Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) rose 9.96 percent to close at $6.18. H.C. Wainwright initiated coverage on Mesoblast with a Buy rating.</li>
<li>
		InfoSonics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifon#NASDAQ">IFON</a>) shares rose 9.76 percent to close at $4.05 after the company announced it&#39;s working with Apple Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) on Latin American expansion and will expand into U.S. markets pending Apple&rsquo;s approval. The company also announced it closed a $3.7-million common stock offering.</li>
<li>
		Goosehead Insurance, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gshd#NASDAQ">GSHD</a>) rose 9.53 percent to close at $18.74.</li>
<li>
		AzurRx BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/azrx#NASDAQ">AZRX</a>) shares climbed 8.96 percent to close at $2.92.</li>
<li>
		Vitamin Shoppe, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vsi#NYSE">VSI</a>) shares surged 8.7 percent to close at $6.25 on Thursday.</li>
<li>
		Axovant Sciences Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axon#NASDAQ">AXON</a>) gained 5.49 percent to close at $4.80 on Thursday after climbing 160.00 percent on Wednesday.</li>
</ul>
&nbsp;
<h3>
	Losers</h3>
<ul>
<li>
		Proteostasis Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pti#NASDAQ">PTI</a>) shares tumbled 38.16 percent to close at $3.03 on Thursday after data from an ongoing Phase 1 Study of PTI-801 in cystic fibrosis patients showed statistically significant improvement in blood glucose levels and the reversal of hyperglycemia in the diabetic cystic fibrosis subpopulation.</li>
<li>
		MiMedx Group Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdxg#NASDAQ">MDXG</a>) dropped 23.39 percent to close at $6.29. MiMedx reported that it will restate financial statements for FY12-FY16 and interim periods of FY17 related to sales recognition. The company also disclosed that its CFO Michael Senken stepped down in June 6, 2018 and Edward Borkowski has been named as interim CFO.</li>
<li>
		Evolus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eols#NASDAQ">EOLS</a>) shares fell 19.51 percent to close at $30.98.</li>
<li>
		SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) shares dipped 19.02 percent to close at $1.66 on Thursday.</li>
<li>
		REV Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/revg#NYSE">REVG</a>) dropped 18.93 percent to close at $14.52 after the company posted downbeat Q2 earnings and lowered its FY18 net income outlook.</li>
<li>
		Medley Management Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mdly#NYSE">MDLY</a>) shares fell 14.81 percent to close at $3.45.</li>
<li>
		United Natural Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/unfi#NASDAQ">UNFI</a>) shares dropped 14.29 percent to close at $39.58. United Natural Foods reported stronger-than-expected results for its third-quarter and raised its fiscal 2018 outlook.</li>
<li>
		Deciphera Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcph#NASDAQ">DCPH</a>) declined 13.56 percent to close at $35.89 after announcing pricing of public offering.</li>
<li>
		Vascular Biogenics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vblt#NASDAQ">VBLT</a>) shares fell 13.33 percent to close at $2.60.</li>
<li>
		ReShape Lifesciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rsls#NASDAQ">RSLS</a>) dropped 12.76 percent to close at $3.42 after the company reported $1.5 million registered direct offering priced at-the-market.</li>
<li>
		Sunesis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snss#NASDAQ">SNSS</a>) dipped 12.72 percent to close at $2.47.</li>
<li>
		Nektar Therapeutics (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nktr#NASDAQ">NKTR</a>) shares tumbled 11.69 percent to close at $52.97.</li>
<li>
		Cytori Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cytx#NASDAQ">CYTX</a>) fell 11.02 percent to close at $2.26.</li>
<li>
		Madrigal Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdgl#NASDAQ">MDGL</a>) dropped 10.46 percent to close at $281.06 on Thursday after reporting pricing of public offering of common stock.</li>
<li>
		PagSeguro Digital Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pags#NYSE">PAGS</a>) fell 10.37 percent to close at $29.81.</li>
<li>
		Seven Stars Cloud Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssc#NASDAQ">SSC</a>) shares dropped 9.58 percent to close at $2.17 on Thursday. Seven Stars Cloud reported a joint venture with The Centre For Digital Revolution.</li>
<li>
		American Superconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsc#NASDAQ">AMSC</a>) shares fell 7.43 percent to close at $6.48. American Superconductor reported upbeat earnings for its fiscal fourth quarter, while sales missed estimates.</li>
<li>
		Cloudera, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cldr#NYSE">CLDR</a>) dropped 6.69 percent to close at $16.03 despite reporting upbeat quarterly results.</li>
<li>
		Axon Enterprise, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aaxn#NASDAQ">AAXN</a>) fell 6.44 percent to close at $63.53. JP Morgan downgraded Axon Enterprise from Overweight to Neutral.</li>
<li>
		Hovnanian Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hov#NYSE">HOV</a>) declined 5.97 percent to close at $1.89 following Q2 results.</li>
<li>
		J M Smucker Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sjm#NYSE">SJM</a>) shares fell 5.37 percent to close at $100.80 after reporting weaker-than-expected Q4 results.</li>
<li>
		First Solar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fslr#NASDAQ">FSLR</a>) slipped 4.1 percent to close at $53.28. Vertical Group downgraded First Solar from Buy to Sell.</li>
</ul>

Toward the end of trading Thursday, the Dow traded up 0.18 percent to 25,190.86 while the NASDAQ declined 1.15 percent to 7,601.21. The S&amp;P also fell, dropping 0.40 percent to 2,761.39.
Leading and Lagging Sectors
	Thursday afternoon, the energy shares surged 1.87 percent. Meanwhile, top gainers in the sector included Chesapeake Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chk#NYSE">CHK</a>) up 9 percent, and Ultra Petroleum Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/upl#NYSE">UPL</a>) up 10 percent.
In trading on Thursday, information technology shares fell 1.36 percent.

	Top Headline
J M Smucker Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sjm#NYSE">SJM</a>) reported weaker-than-expected results for its fourth quarter.
Smucker posted adjusted earnings of $1.93 per share on revenue of $1.781 billion. However, analysts were expecting earnings of $2.20 per share on revenue of $1.81 billion.
JM Smucker expects FY2019 earnings of $8.40 to $8.65 per share, on sales of $8.30 billion. Analysts project earnings of $8.22 per share on sales of $7.38 billion.
&nbsp;
Equities Trading UP
AV Homes, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avhi#NASDAQ">AVHI</a>) shares shot up 29 percent to $21.35 after Taylor Morrison Home Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tmhc#NYSE">TMHC</a>) agreed to acquire AV Homes at $21.50 per share in cash and stock.
Shares of Ophthotech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opht#NASDAQ">OPHT</a>) got a boost, shooting up 48 percent to $4.1576 after the company disclosed that it has entered into gene therapy agreements with University of Florida and University of Pennsylvania.
Top Ships Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tops#NASDAQ">TOPS</a>) shares were also up, gaining 49 percent to $1.15 after the company reported a time charter with a major oil company for its two Suezmax vessels.

	Equities Trading DOWN
	 Proteostasis Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pti#NASDAQ">PTI</a>) shares dropped 35 percent to $3.21 after data from an ongoing Phase 1 Study of PTI-801 in cystic fibrosis patients showed statistically significant improvement in blood glucose levels and the reversal of hyperglycemia in the diabetic cystic fibrosis subpopulation.
Shares of REV Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/revg#NYSE">REVG</a>) were down 21 percent to $14.12 after the company posted downbeat Q2 earnings and lowered its FY18 net income outlook.
MiMedx Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdxg#NASDAQ">MDXG</a>) was down, falling around 23 percent to $6.29. MiMedx reported that it will restate financial statements for FY12-FY16 and interim periods of FY17 related to sales recognition. The company also disclosed that its CFO Michael Senken stepped down in June 6, 2018 and Edward Borkowski has been named as interim CFO.

	Commodities

	In commodity news, oil traded up 1.79 percent to $65.89 while gold traded up 0.14 percent to $1,303.20.
	Silver traded up 0.90 percent Thursday to $16.845, while copper rose 0.43 to $3.276.
	Eurozone
European shares closed mostly lower today. The eurozone&rsquo;s STOXX 600 fell 0.24 percent, the Spanish Ibex Index rose 0.38 percent, while Italy&rsquo;s FTSE MIB Index declined 0.18 percent. Meanwhile the German DAX slipped 0.15 percent, and the French CAC 40 fell 0.17 percent while U.K. shares fell 0.10 percent.
Economics
Initial jobless claims dropped 1,000 to 222,000 in the latest week. However, economists were expecting a 225,000 reading.
Domestic supplies of natural gas increased 92 billion cubic feet for the week ended June 1, the U.S. Energy Information Administration reported. Analysts projected a rise of 90 billion cubic feet.
The consumer credit report for April is schedule for release at 3:00 p.m. ET.
Data on money supply for the recent week will be released at 4:30 p.m. ET.

<h3>
	Gainers</h3>
<ul>
<li>
		Top Ships Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tops#NASDAQ">TOPS</a>) shares climbed 78.6 percent to $1.3751 after the company reported a time charter with a major oil company for its two Suezmax vessels.</li>
<li>
		AV Homes, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avhi#NASDAQ">AVHI</a>) shares jumped 29.2 percent to $21.325 after Taylor Morrison Home Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tmhc#NYSE">TMHC</a>) agreed to acquire AV Homes at $21.50 per share in cash and stock.</li>
<li>
		Axovant Sciences Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axon#NASDAQ">AXON</a>) jumped 26 percent to $5.74 after climbing 160.00 percent on Wednesday.</li>
<li>
		Ophthotech Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opht#NASDAQ">OPHT</a>) shares surged 24.6 percent to $3.49 after the company disclosed that it has entered into gene therapy agreements with University of Florida and University of Pennsylvania.</li>
<li>
		Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>) rose 23.7 percent to $37.923 after reporting a third-quarter earnings and sales beat. The company issued strong fourth-quarter and fiscal 2018 earnings and sales guidance.</li>
<li>
		Five Below, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/five#NASDAQ">FIVE</a>) jumped 22.5 percent to $99.58 after the company reported better-than-expected results for its first quarter The company also issued strong second quarter and fiscal 2018 earnings and sales guidance.</li>
<li>
		Conn&#39;s Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/conn#NASDAQ">CONN</a>) gained 22.1 percent to $31.30 after the company reported better-than-expected results for its first quarter on Thursday.</li>
<li>
		Coffee Holding Co., Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jva#NASDAQ">JVA</a>) rose 16.9 percent to $4.92 following Q2 beat.</li>
<li>
		Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) climbed 13 percent to $6.35. H.C. Wainwright initiated coverage on Mesoblast with a Buy rating.</li>
<li>
		ABM Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>) rose 12.2 percent to $32.55 after reporting upbeat results for its fiscal third quarter.</li>
<li>
		Mirati Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrtx#NASDAQ">MRTX</a>) climbed 11.8 percent to $43.45. Mirati Therapeutics priced its 2.75 million share common stock offering at $38.85 per share.</li>
<li>
		Urban One, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uone#NASDAQ">UONE</a>) gained 11.4 percent to $3.009.</li>
<li>
		Vishay Intertechnology, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vsh#NYSE">VSH</a>) climbed 10.6 percent to $24.10 after reporting a proposed offering of $525 million of convertible senior notes.</li>
<li>
		ShotSpotter, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssti#NASDAQ">SSTI</a>) climbed 10.6 percent to $35.97. JMP Securities initiated coverage on ShotSpotter with a Market Outperform rating.</li>
<li>
		Sonic Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sonc#NASDAQ">SONC</a>) rose 10.5 percent to $29.3975. Sonic reiterated its FY18 outlook and increased its share repurchase authorization from $160 million to $500 million.</li>
<li>
		InfoSonics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifon#NASDAQ">IFON</a>) shares rose 9.2 percent to $4.0301 after the company announced it&#39;s working with Apple Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) on Latin American expansion and will expand into U.S. markets pending Apple&rsquo;s approval. The company also announced it closed a $3.7-million common stock offering.</li>
<li>
		Advaxis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adxs#NASDAQ">ADXS</a>) jumped 7.9 percent to $1.8446 following Q2 results.</li>
<li>
		Donnelley Financial Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dfin#NASDAQ">DFIN</a>) gained 6 percent to $17.13. DA Davidson initiated coverage on Donnelley Financial with a Buy rating.</li>
<li>
		Athersys, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/athx#NASDAQ">ATHX</a>) rose 4 percent to $2.90 after announcing the expansion of a collaboration with Japan-based pharmaceutical company Healios. As part of the revised agreement, Healios received rights to develop and commercialize MultiStem in Japan in exchange for $20 million upfront and up to $360 million in milestone payments.</li>
</ul>

	<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>
	Losers</h3>
<ul>
<li>
		Proteostasis Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pti#NASDAQ">PTI</a>) shares dropped 36.73 percent to $3.10 after data from an ongoing Phase 1 Study of PTI-801 in cystic fibrosis patients showed statistically significant improvement in blood glucose levels and the reversal of hyperglycemia in the diabetic cystic fibrosis subpopulation.</li>
<li>
		REV Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/revg#NYSE">REVG</a>) declined 21 percent to $14.15 after the company posted downbeat Q2 earnings and lowered its FY18 net income outlook.</li>
<li>
		American Superconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsc#NASDAQ">AMSC</a>) shares fell 18.1 percent to $5.7300. American Superconductor reported upbeat earnings for its fiscal fourth quarter, while sales missed estimates.</li>
<li>
		MiMedx Group Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdxg#NASDAQ">MDXG</a>) fell 17.9 percent to $6.7400. MiMedx reported that it will restate financial statements for FY12-FY16 and interim periods of FY17 related to sales recognition. The company also disclosed that its CFO Michael Senken stepped down in June 6, 2018 and Edward Borkowski has been named as interim CFO.</li>
<li>
		ReShape Lifesciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rsls#NASDAQ">RSLS</a>) dropped 15.8 percent to $3.30 after the company reported $1.5 million registered direct offering priced at-the-market.</li>
<li>
		SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) shares fell 15.6 percent to $1.73.</li>
<li>
		Vascular Biogenics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vblt#NASDAQ">VBLT</a>) shares dipped 12.5 percent to $2.625.</li>
<li>
		United Natural Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/unfi#NASDAQ">UNFI</a>) shares fell 8.7 percent to $42.18. United Natural Foods reported stronger-than-expected results for its third-quarter and raised its fiscal 2018 outlook.</li>
<li>
		Ichor Holdings, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ichr#NASDAQ">ICHR</a>) slipped 8.7 percent to $23.505.</li>
<li>
		Hovnanian Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hov#NYSE">HOV</a>) dipped 7.5 percent to $1.86 following Q2 results.</li>
<li>
		CohBar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cwbr#NASDAQ">CWBR</a>) dropped 6.7 percent to $8.26. CohBar appointed Philippe P. Calais, Ph.D., to its Board of Directors, and to the Board&rsquo;s Audit Committee.</li>
<li>
		Axon Enterprise, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aaxn#NASDAQ">AAXN</a>) declined 6.7 percent to $63.385. JP Morgan downgraded Axon Enterprise from Overweight to Neutral.</li>
<li>
		Cloudera, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cldr#NYSE">CLDR</a>) fell 6.5 percent to $16.064 despite reporting upbeat quarterly results.</li>
<li>
		MEI Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meip#NASDAQ">MEIP</a>) shares fell 5.8 percent to $4.52 after rising 15.66 percent on Wednesday.</li>
<li>
		MongoDB, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdb#NASDAQ">MDB</a>) fell 4.2 percent to $49.18 after reporting first-quarter earnings that fell in line with analyst estimates.</li>
<li>
		J M Smucker Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sjm#NYSE">SJM</a>) shares fell 4 percent to $102.3653 after reporting weaker-than-expected Q4 results.</li>
<li>
		First Solar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fslr#NASDAQ">FSLR</a>) slipped 3.7 percent to $53.52. Vertical Group downgraded First Solar from Buy to Sell.</li>
</ul>

36 Stocks Moving In Thursday's Mid-Day Session

Midway through trading Thursday, the Dow traded up 0.46 percent to 25,261.64 while the NASDAQ declined 0.62 percent to 7,641.50. The S&amp;P also fell, dropping 0.04 percent to 2,771.22.
Leading and Lagging Sectors
	On Thursday, the energy shares surged 1.47 percent. Meanwhile, top gainers in the sector included Chesapeake Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chk#NYSE">CHK</a>) up 7 percent, and Ultra Petroleum Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/upl#NYSE">UPL</a>) up 7 percent.
In trading on Thursday, information technology shares fell 1.14 percent.

	Top Headline
J M Smucker Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sjm#NYSE">SJM</a>) reported weaker-than-expected results for its fourth quarter.
Smucker posted adjusted earnings of $1.93 per share on revenue of $1.781 billion. However, analysts were expecting earnings of $2.20 per share on revenue of $1.81 billion.
JM Smucker expects FY2019 earnings of $8.40 to $8.65 per share, on sales of $8.30 billion. Analysts project earnings of $8.22 per share on sales of $7.38 billion.
&nbsp;
Equities Trading UP
AV Homes, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avhi#NASDAQ">AVHI</a>) shares shot up 29 percent to $21.30 after Taylor Morrison Home Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tmhc#NYSE">TMHC</a>) agreed to acquire AV Homes at $21.50 per share in cash and stock.
Shares of Conn&#39;s, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/conn#NASDAQ">CONN</a>) got a boost, shooting up 18 percent to $30.30 after the company reported better-than-expected results for its first quarter on Thursday.
Top Ships Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tops#NASDAQ">TOPS</a>) shares were also up, gaining 64 percent to $1.26 after the company reported a time charter with a major oil company for its two Suezmax vessels.

	Equities Trading DOWN
	 Proteostasis Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pti#NASDAQ">PTI</a>) shares dropped 33 percent to $3.295 after data from an ongoing Phase 1 Study of PTI-801 in cystic fibrosis patients showed statistically significant improvement in blood glucose levels and the reversal of hyperglycemia in the diabetic cystic fibrosis subpopulation.
Shares of REV Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/revg#NYSE">REVG</a>) were down 21 percent to $14.1401 after the company posted downbeat Q2 earnings and lowered its FY18 net income outlook.
MiMedx Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdxg#NASDAQ">MDXG</a>) was down, falling around 23 percent to $6.29. MiMedx reported that it will restate financial statements for FY12-FY16 and interim periods of FY17 related to sales recognition. The company also disclosed that its CFO Michael Senken stepped down in June 6, 2018 and Edward Borkowski has been named as interim CFO.

	Commodities

	In commodity news, oil traded up 1.67 percent to $65.81 while gold traded up 0.02 percent to $1,301.70.
	Silver traded up 0.99 percent Thursday to $16.86, while copper rose 1.44 to $3.309.
	Eurozone
European shares were mostly lower today. The eurozone&rsquo;s STOXX 600 fell 0.34 percent, the Spanish Ibex Index rose 0.33 percent, while Italy&rsquo;s FTSE MIB Index declined 0.32 percent. Meanwhile the German DAX slipped 0.42 percent, and the French CAC 40 fell 0.25 percent while U.K. shares rose 0.08 percent.
Economics
Initial jobless claims dropped 1,000 to 222,000 in the latest week. However, economists were expecting a 225,000 reading.
Domestic supplies of natural gas increased 92 billion cubic feet for the week ended June 1, the U.S. Energy Information Administration reported. Analysts projected a rise of 90 billion cubic feet.
The consumer credit report for April is schedule for release at 3:00 p.m. ET.
Data on money supply for the recent week will be released at 4:30 p.m. ET.

Mid-Day Market Update: Crude Oil Up Over 1.5%; Conn's Shares Rise Following Upbeat Results

Following the market opening Thursday, the Dow traded up 0.43 percent to 25,254.09 while the NASDAQ declined 0.32 percent to 7,664.89. The S&amp;P also rose, gaining 0.11 percent to 2,775.30.
Leading and Lagging Sectors
	Thursday morning, the energy shares surged 1.4 percent. Meanwhile, top gainers in the sector included Chesapeake Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chk#NYSE">CHK</a>) up 6 percent, and Ultra Petroleum Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/upl#NYSE">UPL</a>) up 9 percent.
In trading on Thursday, information technology shares fell 0.32 percent.

	Top Headline
J M Smucker Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sjm#NYSE">SJM</a>) reported weaker-than-expected results for its fourth quarter.
Smucker posted adjusted earnings of $1.93 per share on revenue of $1.781 billion. However, analysts were expecting earnings of $2.20 per share on revenue of $1.81 billion.
JM Smucker expects FY2019 earnings of $8.40 to $8.65 per share, on sales of $8.30 billion. Analysts project earnings of $8.22 per share on sales of $7.38 billion.
&nbsp;
Equities Trading UP
AV Homes, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avhi#NASDAQ">AVHI</a>) shares shot up 29 percent to $21.30 after Taylor Morrison Home Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tmhc#NYSE">TMHC</a>) agreed to acquire AV Homes at $21.50 per share in cash and stock.
Shares of Conn&#39;s, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/conn#NASDAQ">CONN</a>) got a boost, shooting up 23 percent to $31.45 after the company reported better-than-expected results for its first quarter on Thursday.
Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>) shares were also up, gaining 25 percent to $38.44 after reporting a third-quarter earnings and sales beat. The company issued strong fourth-quarter and fiscal 2018 earnings and sales guidance.

	Equities Trading DOWN
	 Proteostasis Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pti#NASDAQ">PTI</a>) shares dropped 36 percent to $3.16 after data from an ongoing Phase 1 Study of PTI-801 in cystic fibrosis patients showed statistically significant improvement in blood glucose levels and the reversal of hyperglycemia in the diabetic cystic fibrosis subpopulation.
Shares of REV Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/revg#NYSE">REVG</a>) were down 22 percent to $13.95 after the company posted downbeat Q2 earnings and lowered its FY18 net income outlook.
MiMedx Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdxg#NASDAQ">MDXG</a>) was down, falling around 15 percent to $7.00. MiMedx reported that it will restate financial statements for FY12-FY16 and interim periods of FY17 related to sales recognition. The company also disclosed that its CFO Michael Senken stepped down in June 6, 2018 and Edward Borkowski has been named as interim CFO.

	Commodities

	In commodity news, oil traded up 0.87 percent to $65.29 while gold traded up 0.05 percent to $1,302.10.
	Silver traded up 1.08 percent Thursday to $16.875, while copper rose 1.47 to $3.31.
	Eurozone
European shares were mostly lower today. The eurozone&rsquo;s STOXX 600 fell 0.22 percent, the Spanish Ibex Index rose 0.39 percent, while Italy&rsquo;s FTSE MIB Index declined 0.31 percent. Meanwhile the German DAX slipped 0.09 percent, and the French CAC 40 fell 0.14 percent while U.K. shares rose 0.25 percent.
Economics
Initial jobless claims dropped 1,000 to 222,000 in the latest week. However, economists were expecting a 225,000 reading.
The Energy Information Administration&rsquo;s weekly report on natural gas stocks in underground storage will be released at 10:30 a.m. ET.
The consumer credit report for April is schedule for release at 3:00 p.m. ET.
Data on money supply for the recent week will be released at 4:30 p.m. ET.

Mid-Morning Market Update: Markets Mostly Higher; J M Smucker Misses Q4 Expectations

A V Homes Shares Up 27.6% To $2105 After Taylor Morrison Announced Agreement To Acquire Co. For $21.50/Share In Cash And Stock

<h3>
	Gainers</h3>
<ul>
<li>
		AV Homes, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avhi#NASDAQ">AVHI</a>) shares rose 24.2 percent to $20.50 in pre-market trading after Taylor Morrison Home Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tmhc#NYSE">TMHC</a>) agreed to acquire AV Homes at $21.50 per share in cash and stock.</li>
<li>
		Conn&#39;s Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/conn#NASDAQ">CONN</a>) rose 20.7 percent to $30.95 in pre-market trading after the company reported better-than-expected results for its first quarter on Thursday.</li>
<li>
		Athersys, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/athx#NASDAQ">ATHX</a>) rose 20.4 percent to $3.36 in pre-market trading after the company reported expansion of collaboration with Healios.</li>
<li>
		Five Below, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/five#NASDAQ">FIVE</a>) rose 16.7 percent to $94.80 in pre-market trading after the company reported better-than-expected results for its first quarter The company also issued strong second quarter and fiscal 2018 earnings and sales guidance.</li>
<li>
		InfoSonics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifon#NASDAQ">IFON</a>) shares rose 16.5 percent to $4.30 in pre-market trading after the company announced it&#39;s working with Apple Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) on Latin American expansion and will expand into U.S. markets pending Apple&rsquo;s approval. The company also announced it closed a $3.7-million common stock offering.</li>
<li>
		Ophthotech Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opht#NASDAQ">OPHT</a>) shares rose 16.5 percent to $3.26 in pre-market trading after the company disclosed that it has entered into gene therapy agreements with University of Florida and University of Pennsylvania.</li>
<li>
		Axovant Sciences Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axon#NASDAQ">AXON</a>) rose 13.2 percent to $5.15 in pre-market trading after climbing 160.00 percent on Wednesday.</li>
<li>
		Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>) rose 10.9 percent to $34.00 in pre-market trading after reporting a third-quarter earnings and sales beat. The company issued strong fourth-quarter and fiscal 2018 earnings and sales guidance.</li>
<li>
		Changyou.com Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyou#NASDAQ">CYOU</a>) shares rose 10.1 percent to $20.76 in pre-market trading.</li>
<li>
		Legacy Reserves LP (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgcy#NASDAQ">LGCY</a>) shares rose 6.8 percent to $6.47 in pre-market trading after gaining 3.41 percent on Wednesday.</li>
<li>
		Pareteum Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/teum#NASDAQ">TEUM</a>) rose 6.1 percent to $2.47 in pre-market trading after the company agreed to acquire Artilium for $104.7 million.</li>
<li>
		Intercept Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icpt#NASDAQ">ICPT</a>) rose 3.8 percent to $76.49 in pre-market trading.</li>
<li>
		ABM Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>) rose 3.5 percent to $30.01 in pre-market trading after reporting upbeat results for its fiscal third quarter.</li>
<li>
		GNC Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gnc#NYSE">GNC</a>) rose 3.5 percent to $3.30 in pre-market trading after gaining 4.59 percent on Wednesday.</li>
<li>
		Seaspan Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ssw#NYSE">SSW</a>) gained 3 percent to $8.99 after declining 2.57 percent on Wednesday.</li>
</ul>

	Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>
	Losers</h3>
<ul>
<li>
		Proteostasis Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pti#NASDAQ">PTI</a>) shares fell 25.5 percent to $3.65 in pre-market trading after data from an ongoing Phase 1 Study of PTI-801 in cystic fibrosis patients showed statistically significant improvement in blood glucose levels and the reversal of hyperglycemia in the diabetic cystic fibrosis subpopulation.</li>
<li>
		MiMedx Group Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdxg#NASDAQ">MDXG</a>) fell 23.9 percent to $6.25in pre-market trading. MiMedx reported that it will restate financial statements for FY12-FY16 and interim periods of FY17 related to sales recognition. The company also disclosed that its CFO Michael Senken stepped down in June 6, 2018 and Edward Borkowski has been named as interim CFO.</li>
<li>
		REV Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/revg#NYSE">REVG</a>) fell 16.6 percent to $14.94 in pre-market trading after the company posted downbeat Q2 earnings and lowered its FY18 net income outlook.</li>
<li>
		American Superconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsc#NASDAQ">AMSC</a>) shares fell 10 percent to $6.30 in pre-market trading. American Superconductor reported upbeat earnings for its fiscal fourth quarter, while sales missed estimates.</li>
<li>
		J M Smucker Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sjm#NYSE">SJM</a>) shares fell 9.9 percent to $96.00 in pre-market trading after reporting weaker-than-expected Q4 results.</li>
<li>
		Thor Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tho#NYSE">THO</a>) fell 8.6 percent to $90.00 in the pre-market trading session after the company reported Q3 miss. The company&rsquo;s CEO Bob Martin said Q4 earnings will be affected by inflationary prices and impact from tariffs.</li>
<li>
		Curis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cris#NASDAQ">CRIS</a>) shares fell 7.1 percent to $2.22 in pre-market trading.</li>
<li>
		Cloudera, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cldr#NYSE">CLDR</a>) fell 6.3 percent to $16.10 in pre-market trading despite reporting upbeat quarterly results.</li>
<li>
		Intelsat S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/i#NYSE">I</a>) fell 6.1 percent to $17.25 in pre-market trading after rising 3.43 percent on Wednesday.</li>
<li>
		MEI Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meip#NASDAQ">MEIP</a>) shares fell 5.6 percent to $4.53 in pre-market trading after rising 15.66 percent on Wednesday.</li>
<li>
		MongoDB, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdb#NASDAQ">MDB</a>) fell 4.2 percent to $49.10 in pre-market trading after reporting first-quarter earnings that fell in line with analyst estimates.</li>
<li>
		United Natural Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/unfi#NASDAQ">UNFI</a>) shares fell 3.2 percent to $44.73 in pre-market trading. United Natural Foods reported stronger-than-expected results for its third-quarter and raised its fiscal 2018 outlook.</li>
</ul>

CRIS

Changyou Limited American Depositary Share

CYOU

ICPT

LGCY

TEUM

27 Stocks Moving In Thursday's Pre-Market Session

Highlights:Acquisition price of approximately $490 million yields an attractive purchase multiple of 1.1x bookExpect $30 million in annualized synergies from acquisitionGrowing the affordable active adult productHighlights:
<ul>
<li>Acquisition price of approximately $490 million yields an attractive purchase multiple of 1.1x book</li>
<li>Expect $30 million in annualized synergies from acquisition</li>
<li>Growing the affordable active adult product offerings in Orlando, Phoenix and Raleigh to complement existing Taylor Morrison communities</li>
<li>Expansion into the more affordable, first-time buyer segment</li>
<li>Significantly increases scale and market share in five major housing markets</li>
</ul>
Taylor Morrison Home Corporation (NYSE:<a class="ticker" href="/stock/TMHC#NYSE">TMHC</a>), a leading national homebuilder and developer, and AV Homes, Inc. (NASDAQ:<a class="ticker" href="/stock/AVHI#NASDAQ">AVHI</a>), a developer and builder of residential communities in Florida, the Carolinas, Arizona and Texas, today announced that they have entered into a definitive agreement pursuant to which Taylor Morrison will acquire all of the outstanding shares of AV Homes common stock at $21.50 per share in a cash and stock transaction valued (including outstanding AV Homes debt) at approximately $963 million.&nbsp;The transaction has been unanimously approved by the Boards of Directors of both Taylor Morrison and AV Homes and will be submitted to the stockholders of AV Homes for approval.&nbsp;The transaction is expected to close late in the third quarter or early in the fourth quarter of 2018 and the closing is subject to customary closing conditions. TPG Capital, the holder of approximately 40% of AV Homes common stock, has agreed to vote all of its shares of AV Homes common stock in favor of the transaction. Under the terms of the agreement, AV Homes stockholders will have the option to receive, at their election, consideration per share equal to (i) $21.50 in cash, (ii) 0.9793 shares of Taylor Morrison Class A common stock or (iii) the combination of $12.64 in cash and 0.4034 shares of Taylor Morrison Class A common stock, subject to an overall proration of approximately 60% cash and 40% stock.&nbsp;On a pro forma basis, AV Homes stockholders are expected to own up to approximately 10% of the combined company, subject to conversion mechanics applicable to holders of AV Homes&#39; convertible notes.&nbsp; &quot;The joining of Taylor Morrison and AV Homes supports our strategic growth priority by bringing us deeper into five of our current markets, adding Jacksonville to the portfolio, and further expanding our offerings in the affordable first-time buyer and active adult consumer segments,&quot; said Sheryl Palmer, chairman and CEO of Taylor Morrison. &quot;This transaction, subject to customary closing conditions, will serve as a means to further enhance our land pipeline in the right locations, potentially offsetting some future land purchases, while simultaneously delivering land to our homebuilding operations with mature communities. What&#39;s more, we believe the commonalities in product offerings and consumer groups will create opportunities for scale efficiencies and enhance our national footprint while creating top and bottom-line performance improvement.&quot; Roger A. Cregg, President and Chief Executive Officer of AV Homes, Inc., said, &quot;We are pleased with the significant progress AV Homes has made over the last several years executing our growth strategy, including being recognized as the fastest growing public homebuilder in both 2015 and 2016. Through our focus on consumer segmentation and geographical diversification, we have grown our position in both existing and new attractive metropolitan areas. By combining with Taylor Morrison, one of the country&#39;s finest homebuilders, we will create a premier homebuilder in some of the country&#39;s highest growth areas and drive accretive returns for our shareholders for years to come.&quot; Citigroup Global Markets, Inc. served as the financial advisor to Taylor Morrison and Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP acted as Taylor Morrison&#39;s legal counsel.&nbsp;J.P. Morgan Securities LLC and Moelis &amp; Company

Taylor Morrison Announces Agreement To Acquire AV Homes At $21.50 Per Share In Cash And Stock

<h3>
	Gainers</h3>
<ul>
<li>
		Goosehead Insurance, Inc. (NASDAQ: <a class="ticker" href="/stock/gshd#NASDAQ">GSHD</a>) shares climbed 57.5 percent to close at $15.75 on Friday. Goosehead Insurance priced its IPO at $10 per share.</li>
<li>
		Genprex, Inc. (NASDAQ: <a class="ticker" href="/stock/gnpx#NASDAQ">GNPX</a>) surged 38.27 percent to close at $15.21 on Friday. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn&#39;t been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.</li>
<li>
		Docusign Inc (NASDAQ: <a class="ticker" href="/stock/docu#NASDAQ">DOCU</a>) climbed 37 percent to close at $39.73. DocuSign priced IPO at $29 per share.</li>
<li>
		Smartsheet Inc (NASDAQ: <a class="ticker" href="/stock/smar#NASDAQ">SMAR</a>) rose 30 percent to close at $19.50. Smartsheet priced IPO at $15 per share.</li>
<li>
		Enova International, Inc. (NYSE: <a class="ticker" href="/stock/enva#NYSE">ENVA</a>) gained 27.21 percent to close at $28.75 following Q1 results.</li>
<li>
		DMC Global Inc. (NASDAQ: <a class="ticker" href="/stock/boom#NASDAQ">BOOM</a>) shares rose 24.33 percent to close at $39.35 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.</li>
<li>
		InVivo Therapeutics Holdings Corp. (NASDAQ: <a class="ticker" href="/stock/nviv#NASDAQ">NVIV</a>) gained 21.17 percent to close at $7.84.</li>
<li>
		Celyad SA (NASDAQ: <a class="ticker" href="/stock/cyad#NASDAQ">CYAD</a>) shares climbed 19.66 percent to close at $34.70. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.</li>
<li>
		Aqua Metals, Inc. (NASDAQ: <a class="ticker" href="/stock/aqms#NASDAQ">AQMS</a>) gained 19.08 percent to close at $3.37.</li>
<li>
		SVB Financial Group (NASDAQ: <a class="ticker" href="/stock/sivb#NASDAQ">SIVB</a>) shares surged 18.74 percent to close at $305.61 following strong quarterly results.</li>
<li>
		CEL-SCI Corporation (NYSE: <a class="ticker" href="/stock/cvm#NYSE">CVM</a>) gained 16.99 percent to close at $2.41.</li>
<li>
		Brightcove Inc. (NASDAQ: <a class="ticker" href="/stock/bcov#NASDAQ">BCOV</a>) climbed 15.62 percent to close at $9.25 following Q1 results.</li>
<li>
		eHealth, Inc. (NASDAQ: <a class="ticker" href="/stock/ehth#NASDAQ">EHTH</a>) rose 13.63 percent to close at $18.26 as the company posted upbeat Q1 results.</li>
<li>
		Brookdale Senior Living Inc. (NYSE: <a class="ticker" href="/stock/bkd#NYSE">BKD</a>) gained 13.63 percent to close at $7.42. Brookdale entered into mutually-beneficial agreements with Ventas to combine and extend leases for 128 communities.</li>
<li>
		BJ&#39;s Restaurants, Inc. (NASDAQ: <a class="ticker" href="/stock/bjri#NASDAQ">BJRI</a>) climbed 13.42 percent to close at $56.20 following Q1 results.</li>
<li>
		Knowles Corporation (NYSE: <a class="ticker" href="/stock/kn#NYSE">KN</a>) rose 10.76 percent to close at $12.35 as the company reported Q1 results.</li>
<li>
		Sprint Corporation (NYSE: S) shares gained 8.33 percent to close at $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-Mobile Us Inc (NASDAQ: <a class="ticker" href="/stock/tmus#NASDAQ">TMUS</a>) are proceeding and could even be completed &quot;as early as next week.&quot; The report cautioned &quot;there is no certainty that a deal will be reached.&quot;</li>
<li>
		Expedia Group, Inc. (NASDAQ: <a class="ticker" href="/stock/expe#NASDAQ">EXPE</a>) shares rose 8.2 percent to close at $115.07 after the company reported stronger-than-expected earnings for its first quarter on Thursday.</li>
<li>
		Cocrystal Pharma, Inc. (NASDAQ: <a class="ticker" href="/stock/cocp#NASDAQ">COCP</a>) rose 8.13 percent to close at $2.26 on Friday after declining 25.09 percent on Thursday.</li>
<li>
		Brinker International, Inc. (NYSE: <a class="ticker" href="/stock/eat#NYSE">EAT</a>) rose 7.93 percent to close at $44.65. RBC Capital upgraded Brinker from Sector Perform to Outperform.</li>
<li>
		Baidu, Inc. (NASDAQ: <a class="ticker" href="/stock/bidu#NASDAQ">BIDU</a>) gained 5.55 percent to close at $251.93 following upbeat Q1 profit.</li>
<li>
		ImmunoGen, Inc. (NASDAQ: <a class="ticker" href="/stock/imgn#NASDAQ">IMGN</a>) shares rose 4.28 percent to close at $10.97 after the company announced &#39;successful completion of interim analysis&#39; for FORWARD I Phase 3 mirvetuximab soravtansine trial.</li>
<li>
		Amazon.com, Inc. (NASDAQ: <a class="ticker" href="/stock/amzn#NASDAQ">AMZN</a>) rose 3.6 percent to close at $1,572.62 after the company posted upbeat results for its first quarter. The company sees second quarter operating income of $1.1 billion - $1.9 billion and sales of $51 billion - $54 billion.</li>
</ul>
<h3>
	 
	Losers</h3>
<ul>
<li>
		Aquantia Corp. (NYSE: <a class="ticker" href="/stock/aq#NYSE">AQ</a>) shares tumbled 24.62 percent to close at $10.47 following Q1 results.</li>
<li>
		Flex Ltd. (NASDAQ: <a class="ticker" href="/stock/flex#NASDAQ">FLEX</a>) declined 21.69 percent to close at $13.03 after a mixed fourth quarter report.</li>
<li>
		World Fuel Services Corporation (NYSE: <a class="ticker" href="/stock/int#NYSE">INT</a>) dipped 21.28 percent to close at $21.97 following Q1 results.</li>
<li>
		National Instruments Corporation (NASDAQ: <a class="ticker" href="/stock/nati#NASDAQ">NATI</a>) fell 20.11 percent to close at $39.45 after reporting Q1 results.</li>
<li>
		Biglari Holdings Inc. (NYSE: <a class="ticker" href="/stock/bh#NYSE">BH</a>) dropped 20.05 percent to close at $338.40. Washington Prime Group will replace Biglari Holdings in the S&amp;P SmallCap 600 on Tuesday, May 1.</li>
<li>
		FormFactor, Inc. (NASDAQ: <a class="ticker" href="/stock/form#NASDAQ">FORM</a>) slipped 16 percent to close at $11.55. FormFactor is expected to release Q1 results on May 2.</li>
<li>
		Data I/O Corporation (NASDAQ: <a class="ticker" href="/stock/daio#NASDAQ">DAIO</a>) declined 15.66 percent to close at $6.14 following Q1 results.</li>
<li>
		CalAmp Corp. (NASDAQ: <a class="ticker" href="/stock/camp#NASDAQ">CAMP</a>) fell 14.75 percent to close at $19.76 after reporting Q4 results.</li>
<li>
		Liberty Broadband Corporation (NASDAQ: <a class="ticker" href="/stock/lbrda#NASDAQ">LBRDA</a>) dipped 14.56 percent to close at $69.25.</li>
<li>
		United States Steel Corporation (NYSE: <a class="ticker" href="/stock/x#NYSE">X</a>) declined 14.14 percent to close at $32.37 following Q1 results.</li>
<li>
		Federated Investors, Inc. (NYSE: <a class="ticker" href="/stock/fii#NYSE">FII</a>) shares fell 13.13 percent to close at $26.99 after the company posted downbeat quarterly earnings.</li>
<li>
		Teligent, Inc. (NASDAQ: <a class="ticker" href="/stock/tlgt#NASDAQ">TLGT</a>) shares declined 12.64 percent to close at $3.11 on news it will exchange $65 million of 3.75% senior convertible notes due 2019 for $78 million of 4.75% senior convertible notes due 2023.</li>
<li>
		AgEagle Aerial Systems, Inc. (NASDAQ: <a class="ticker" href="/stock/uavs#NASDAQ">UAVS</a>) dipped 11.94 percent to close at $2.36.</li>
<li>
		SITO Mobile, Ltd. (NASDAQ: <a class="ticker" href="/stock/sito#NASDAQ">SITO</a>) shares fell 11.76 percent to close at $3.45 on Friday.</li>
<li>
		Charter Communications, Inc. (NASDAQ: <a class="ticker" href="/stock/chtr#NASDAQ">CHTR</a>) shares dropped 11.68 percent to close at $263.325 as the company posted Q1 results.</li>
<li>
		KBS Fashion Group Limited (NASDAQ: <a class="ticker" href="/stock/kbsf#NASDAQ">KBSF</a>) shares fell 11.47 percent to close at $4.71.</li>
<li>
		athenahealth, Inc. (NASDAQ: <a class="ticker" href="/stock/athn#NASDAQ">ATHN</a>) dropped 10.89 percent to close at $127.45 after reporting Q1 results.</li>
<li>
		AV Homes, Inc. (NASDAQ: <a class="ticker" href="/stock/avhi#NASDAQ">AVHI</a>) dropped 10.65 percent to close at $17.20 following Q1 results.</li>
<li>
		Piper Jaffray Companies (NYSE: <a class="ticker" href="/stock/pjc#NYSE">PJC</a>) dipped 10.6 percent to close at $75.45 on Friday.</li>
<li>
		Sony Corporation (NYSE: <a class="ticker" href="/stock/sne#NYSE">SNE</a>) shares fell 9.33 percent to close at $45.50 after reporting Q4 results.</li>
<li>
		Civeo Corporation (NYSE: <a class="ticker" href="/stock/cveo#NYSE">CVEO</a>) declined 8.57 percent to close at $3.52. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.</li>
<li>
		ATN International, Inc. (NASDAQ: <a class="ticker" href="/stock/atni#NASDAQ">ATNI</a>) dropped 6.81 percent to close at $57.03. BWS Financial downgraded ATN International from Hold to Sell.</li>
<li>
		LogMeIn Inc (NASDAQ: <a class="ticker" href="/stock/logm#NASDAQ">LOGM</a>) fell 4.1 percent to close at $114.70. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.</li>
</ul>

AMZN

AQMS

ATHN

ATNI

BCOV

BIDU

BJRI

BOOM

CAMP

CHTR

COCP

CVEO

CYAD

DAIO

DOCU

EHTH

ENVA

EXPE

FLEX

FORM

GNPX

IMGN

KBSF

LBRDA

LOGM

NATI

NVIV

SITO

SIVB

SMAR

TLGT

TMUS

UAVS

46 Biggest Movers From Friday

AV Homes Shares Down 11.4% After Co. Thursday Reported Q1 Miss

<h3>
	Gainers</h3>
<ul>
<li>
		Genprex, Inc. (NASDAQ: <a class="ticker" href="/stock/gnpx#NASDAQ">GNPX</a>) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn&#39;t been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.</li>
<li>
		Celyad SA (NASDAQ: <a class="ticker" href="/stock/cyad#NASDAQ">CYAD</a>) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.</li>
<li>
		DMC Global Inc. (NASDAQ: <a class="ticker" href="/stock/boom#NASDAQ">BOOM</a>) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.</li>
<li>
		eHealth, Inc. (NASDAQ: <a class="ticker" href="/stock/ehth#NASDAQ">EHTH</a>) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.</li>
<li>
		Enova International, Inc. (NYSE: <a class="ticker" href="/stock/enva#NYSE">ENVA</a>) climbed 20.4 percent to $27.20 following Q1 results.</li>
<li>
		SVB Financial Group (NASDAQ: <a class="ticker" href="/stock/sivb#NASDAQ">SIVB</a>) shares jumped 18.2 percent to $304.135 following strong quarterly results.</li>
<li>
		Knowles Corporation (NYSE: <a class="ticker" href="/stock/kn#NYSE">KN</a>) gained 13.9 percent to $12.70 as the company reported Q1 results.</li>
<li>
		Zymeworks Inc. (NYSE: <a class="ticker" href="/stock/zyme#NYSE">ZYME</a>) gained 13.8 percent to $17.36.</li>
<li>
		Cocrystal Pharma, Inc. (NASDAQ: <a class="ticker" href="/stock/cocp#NASDAQ">COCP</a>) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.</li>
<li>
		ImmunoGen, Inc. (NASDAQ: <a class="ticker" href="/stock/imgn#NASDAQ">IMGN</a>) shares surged 11.7 percent to $11.75 after the company announced &#39;successful completion of interim analysis&#39; for FORWARD I Phase 3 mirvetuximab soravtansine trial.</li>
<li>
		Eloxx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="/stock/elox#NASDAQ">ELOX</a>) gained 9.5 percent to $12.70.</li>
<li>
		Expedia Group, Inc. (NASDAQ: <a class="ticker" href="/stock/expe#NASDAQ">EXPE</a>) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.</li>
<li>
		Sprint Corporation (NYSE: <a class="ticker" href="/stock/s#NYSE">S</a>) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-Mobile Us Inc (NASDAQ: <a class="ticker" href="/stock/tmus#NASDAQ">TMUS</a>) are proceeding and could even be completed &quot;as early as next week.&quot; The report cautioned &quot;there is no certainty that a deal will be reached.&quot;</li>
<li>
		Brinker International, Inc. (NYSE: <a class="ticker" href="/stock/eat#NYSE">EAT</a>) gained 5.8 percent to $43.75. RBC Capital upgraded Brinker from Sector Perform to Outperform.</li>
<li>
		Amazon.com, Inc. (NASDAQ: <a class="ticker" href="/stock/amzn#NASDAQ">AMZN</a>) rose 4.9 percent to $1,590.69 after the company posted upbeat results for its first quarter. The company sees second quarter operating income of $1.1 billion - $1.9 billion and sales of $51 billion - $54 billion.</li>
<li>
		Baidu, Inc. (NASDAQ: <a class="ticker" href="/stock/bidu#NASDAQ">BIDU</a>) rose 4.6 percent to $249.75 following upbeat Q1 profit.</li>
</ul>
&nbsp;
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>
	Losers</h3>
<ul>
<li>
		World Fuel Services Corporation (NYSE: <a class="ticker" href="/stock/int#NYSE">INT</a>) tumbled 18 percent to $22.90 following Q1 results.</li>
<li>
		Biglari Holdings Inc. (NYSE: <a class="ticker" href="/stock/bh#NYSE">BH</a>) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&amp;P SmallCap 600 on Tuesday, May 1.</li>
<li>
		Flex Ltd. (NASDAQ: <a class="ticker" href="/stock/flex#NASDAQ">FLEX</a>) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.</li>
<li>
		FormFactor, Inc. (NASDAQ: <a class="ticker" href="/stock/form#NASDAQ">FORM</a>) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.</li>
<li>
		Data I/O Corporation (NASDAQ: <a class="ticker" href="/stock/daio#NASDAQ">DAIO</a>) dropped 14.3 percent to $6.24 following Q1 results.</li>
<li>
		National Instruments Corporation (NASDAQ: <a class="ticker" href="/stock/nati#NASDAQ">NATI</a>) fell 14.3 percent to $ 42.34 after reporting Q1 results.</li>
<li>
		United States Steel Corporation (NYSE: <a class="ticker" href="/stock/x#NYSE">X</a>) dipped 14.2 percent to $32.37 following Q1 results.</li>
<li>
		Civeo Corporation (NYSE: <a class="ticker" href="/stock/cveo#NYSE">CVEO</a>) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.</li>
<li>
		athenahealth, Inc. (NASDAQ: <a class="ticker" href="/stock/athn#NASDAQ">ATHN</a>) fell 12.4 percent to $125.310 after reporting Q1 results.</li>
<li>
		Charter Communications, Inc. (NASDAQ: <a class="ticker" href="/stock/chtr#NASDAQ">CHTR</a>) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.</li>
<li>
		Value Line, Inc. (NASDAQ: <a class="ticker" href="/stock/valu#NASDAQ">VALU</a>) fell 11.3 percent to $19.10.</li>
<li>
		Federated Investors, Inc. (NYSE: <a class="ticker" href="/stock/fii#NYSE">FII</a>) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.</li>
<li>
		AV Homes, Inc. (NASDAQ: <a class="ticker" href="/stock/avhi#NASDAQ">AVHI</a>) declined 10.7 percent to $17.20 following Q1 results.</li>
<li>
		CalAmp Corp. (NASDAQ: <a class="ticker" href="/stock/camp#NASDAQ">CAMP</a>) dropped 9.4 percent to $21.01 after reporting Q4 results.</li>
<li>
		Tandem Diabetes Care, Inc. (NASDAQ: <a class="ticker" href="/stock/tndm#NASDAQ">TNDM</a>) shares fell 8.9 percent to $7.280 following mixed Q1 results.</li>
<li>
		Sony Corporation (NYSE: <a class="ticker" href="/stock/sne#NYSE">SNE</a>) shares fell 8.4 percent to $45.97 after reporting Q4 results.</li>
<li>
		LogMeIn Inc (NASDAQ: <a class="ticker" href="/stock/logm#NASDAQ">LOGM</a>) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.</li>
<li>
		Eleven Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="/stock/ebio#NASDAQ">EBIO</a>) fell 7.7 percent to $2.17.</li>
<li>
		ATN International, Inc. (NASDAQ: <a class="ticker" href="/stock/atni#NASDAQ">ATNI</a>) dropped 7.2 percent to $56.7825. BWS Financial downgraded ATN International from Hold to Sell.</li>
</ul>

EBIO

ELOX

TNDM

VALU

ZYME

35 Stocks Moving In Friday's Mid-Day Session

Av Homes Q1 EPS $(0.10) Misses $0.10 Est., Sales $152.008M Misses $189.51M Est.

Guidance

AV Homes Sees FY18 Adj. EBITDA ~$90M

AV Homes Reports Q4 Adj. EPS $0.40 vs $0.41 Est., Sales $280.8M vs $300.6M Est.

Vaso to list on Nasdaq via SPAC merger

SRK Capital H2 2023 Investor Letter

Achari Ventures Corp I (AVHI) has released an update. Achari Ventures Holdings Corp. I has exercised its option to extend the deadline for completi...

Achari Ventures Corp I Extends Business Combination Deadline

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Achari Ventures Hldgs (NASDAQ:<a href="https://investorplace.com/stock-quotes/avhi-stock-quote/">AVHI</a>) just reported results for the fourth quarter of 2023.<ul><li>Achari Ventures Hldgs reported earnings per share of -13 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/avhi-stock-earnings-achari-ventures-hldgs-for-q4-of-2023/">AVHI Stock Earnings: Achari Ventures Hldgs Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

AVHI Stock Earnings: Achari Ventures Hldgs Reported Results for Q4 2023

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
To find the best undiscovered <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>, first take a look at the over-the-counter (OTC) market. Why? Many of the best bargains among penny stocks, or stocks trading for $5 per share or less, can be found among equities that trade OTC.



Smaller and less liquid, institutional investors are less active in the OTC space. This can give individual investors the edge, as stock prices can often fail to fully take into account a stock&rsquo;s underlying value. Either from company-specific catalysts, or from a &ldquo;value is its own catalyst&rdquo; scenario playing out. This creates plenty of opportunity to find and make asymmetric wagers, or situations where upside potential vastly exceeds downside risk.



Having said this, even among penny stocks listed on major markets, you can find names that are both dirt-cheap and under-the-radar. Mainly, among listed penny stocks that are classified as microcap stocks. These are stocks with market capitalizations of $300 million or less.



A mix of OTC and major market-listed names, these are the top seven undiscovered penny stocks to consider buying right now.



<h2>Acacia Research (ACTG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/actg-1600-300x169.jpg" alt="Acacia Research Corporation website homepage"><div>Source: Pavel Kapysh / Shutterstock.com</div></div>Admittedly, one can argue that Main Street and Wall Street investors have already somewhat discovered Acacia Research (NASDAQ:<a href="https://investorplace.com/stock-quotes/actg-stock-quote/">ACTG</a>). Still, shares in this entity have yet to experience a breakout moment, in terms of market popularity and full price discovery. However, this may be changing.



Acacia Research is a holding company, controlled by investment firm Starboard Value. In prior coverage of ACTG stock, I&rsquo;ve talked about <a href="https://investorplace.com/2022/06/7-value-stocks-to-buy-priced-at-less-than-their-book-value/">Acacia&rsquo;s origins</a> as a net operating loss. And its efforts to monetize these tax loss carryforwards through the acquisition of undervalued companies. After several years of sideways price performance, ACTG has bolted higher so far in 2024. Mostly, due to the unveiling of promising news when Acacia reported its <a href="https://feeds.issuerdirect.com/news-release.html?newsid=4720784673251294">full-year 2023 results</a> back in March.



Realizing gains from a prior investment, and making a big bet on oil and gas, Acacia appears well-positioned to start hitting some big home runs. Best of all, even after a 25% move higher year-to-date, ACTG continues to trade at a discount to book value. As InvestorPlace&rsquo;s Yiannis Zourmpanos recently pointed out, Acacia has <a href="https://investorplace.com/2024/06/3-undiscovered-stocks-set-to-double-your-money/">over $400 million</a> in cash on hand, more than enough to plow into its next big deal.



<h2>Barfresh Food Group (BRFH)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/09/baby-food-300x169.jpg" alt="An image from above three cups of baby food, with little bites of vegetables scattered around them."><div>Source: Shutterstock</div></div>Barfresh Food Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/brfh-stock-quote/">BRFH</a>) has more than doubled over the past month. But it&rsquo;s still a name one can arguably classify as one of the undiscovered penny stocks. In a nutshell, Barfresh Food Group makes and sells smoothie and juice products. These products are sold primarily to schools, where they are served as part of school lunches.



Due to poor fiscal performance, BRFH stock sank from prices nearing $8 per share in 2022, to as low as $1 per share earlier this year. However, since May, shares have been making an incredible comeback. First, Barfresh bolted higher upon the release of <a href="https://feeds.issuerdirect.com/news-release.html?newsid=5265729059692397">improved results</a> and promising corporate updates. Second, a stock market commentator has recently started to spread the word about BRFH&rsquo;s upside potential.



As Substack publisher D&amp;A Metropolitan put it in his bull case, the &ldquo;<a href="https://dametropolitan.substack.com/p/barfreshs-juice-is-worth-the-squeeze">juice is worth the squeeze</a>&rdquo; with Barfresh. Experiencing a resurgence in demand from schools, Barfresh could also soon make a move into other sales channels. Per the commentator, this company could be worth between $100 million and $500 million in a few years. Not too shabby, given that, even after the big run up, BRFH has a valuation of less than $50 million.



<h2>Butler National (BUKS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/futuristic-engine-rendering-aerospace-300x169.png" alt="An image of a futuristic aerospace engine rendering"><div>Source: solarseven / Shutterstock</div></div>Butler National (OTCMKTS:<a href="https://investorplace.com/stock-quotes/buks-stock-quote/">BUKS</a>) is another one of the undiscovered penny stocks waiting for its next big liftoff moment. In the past, I&rsquo;ve talked about how this holding company trades at deep value prices. BUKS, with interests in aerospace and casino gaming, trades for only 8.5 times earnings. Meanwhile, both aerospace and <a href="https://investorplace.com/industries/consumer-discretionary/travel/casino/">casino stocks</a> trade at far greater earnings multiples.



Earlier this year it seemed <a href="https://investorplace.com/2024/02/7-undiscovered-penny-stocks-poised-for-meteoric-rises/">a spate of management changes in 2023</a> would kick BUKS stock into high gear. Admittedly, so far there has yet to be any &ldquo;big moves&rdquo; strategically, but there have been some signs of progress. Back in February, Butler added <a href="https://www.butlernational.com/butler-national-enhances-board-to-reinforce-commitment-to-long-term-shareholder-value/">two independent directors</a> to its board. One of these directors, Joseph P. Daly, is one of the company&rsquo;s largest outside shareholders, with a <a href="https://www.butlernational.com/wp-content/uploads/2024/05/buks20230815_def14a.pdf">9% stake</a>.



While not certain, Daly and the other independent directors could be working behind the scenes, to push for the best course of action to drive the next big boost for shares. Butler&rsquo;s aerospace unit could be a prime target for a strategic acquirer. The same can be said about the company&rsquo;s casino property as well.



<h2>Elite Pharmaceuticals (ELTP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/06/research-lab-1600-300x169.jpg" alt="Scientist using a microscope"><div>Source: Maksim Shmeljov / Shutterstock.com</div></div>With Elite Pharmaceuticals (OTCMKTS:<a href="https://investorplace.com/stock-quotes/eltp-stock-quote/">ELTP</a>) up five fold over the past year, this is yet another of the undiscovered penny stocks. Don&rsquo;t be discouraged by the appearance that microcap investors may have caught onto the opportunity with pharma firm. Elite has a catalyst in motion that could drive an even larger amount of market attention.



The ELTP stock catalyst I&rsquo;m talking about is the company&rsquo;s key pipeline candidate, a generic anti-rheumatic treatment. Earlier this month, I discussed how this candidate <a href="https://investorplace.com/2024/06/7-strong-buy-penny-stocks-to-buy-now-june-2024/">recently received regulatory approval</a>. This paves the way for Elite to monetize this product. Sure, it&rsquo;s not as if this pharma firm has a blockbuster drug in the making with this candidate.



However, with a total addressable market of $64.3 million, capturing a good share of this market could mean further material improvements to Elite&rsquo;s sales and profitability. Over the past twelve months, revenue has totaled $47.3 million. Shares could rally on more progress with this catalyst, but that could be only the start. Now back in the high growth fast lane, it wouldn&rsquo;t be surprising if ELTP made additional moves to raise its profile, such as <a href="https://public.com/learn/uplistings-explained-examples-of-uplisted-stocks?wpsrc=Organic+Search&amp;wpsn=www.google.com">a stock market uplisting</a>.



<h2>Fortitude Gold (FTCO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/05/gold-mining-stocks1600-300x169.png" alt="Gold Nugget mining from the River in Austria, real Gold. Gold mining stocks"><div>Source: Aleksandrkozak / Shutterstock.com</div></div>Based in Colorado Springs, Colorado, Fortitude Gold (OTCMKTS:<a href="https://investorplace.com/stock-quotes/ftco-stock-quote/">FTCO</a>) is a gold producer. The company operates mining properties in the U.S. state of Nevada. Fortitude has a track record of generating steady earnings from its established mining operations. Further, the company also pays out <a href="https://www.fortitudegold.com/news/fortitude-gold-declares-june-2024-monthly-dividend">a monthly 4 cent per share dividend</a> to investors.



If FTCO stock were to trade on a major exchange, dividend investors would be all over it. However, since Fortitude Gold shares trade in the OTC market, it has attracted far less attention. This works highly in the favor of those in the know, since at current prices FTCO&rsquo;s payout gives the stock a forward yield of 11.29%.



That&rsquo;s not all. As I have pointed out before, <a href="https://investorplace.com/2024/01/best-monthly-dividend-stocks-for-2024/">there may be big upside potential</a> on the table as well with FTCO. While spot gold prices have pulled back slightly, they remain up by around 20.5% over the past year. Further macro and monetary policy changes could send gold even higher. As is the case with gold miners, high operating leverage suggests the potential for outsized improvements in profitability, on relatively smaller increases in the gold spot price.



<h2>Lesaka Technologies (LSAK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/bnpl-ecommerce-fintech-300x169.png" alt="An image of a cellphone surrounded by money and shopping bags, a calendar and shopping cart on the screen; schedule payment"><div>Source: ArtemisDiana/Shutterstock</div></div>Lesaka Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lsak-stock-quote/">LSAK</a>) is a South African fintech firm, specializing in providing payment and other financial services. Its main focus is on the informal economy in its home market, as well in adjacent markets in Southern Africa.



There are two reasons why LSAK stock could go from being one of the undiscovered penny stocks, to garnering a far greater level of market attention. First, as seen in Lesaka&rsquo;s latest quarterly earnings release, <a href="https://ir.lesakatech.com/pdf/quarterly-results/2024/q3/lsak-q3-2024-earnings-press-release.pdf">operating results are steadily improving</a>. Recent bolt-on acquisitions could help the company make a full-on move to consistent profitability. Once the company&rsquo;s fundamentals appear stronger on a screener, this could result in greater investor inflows into shares.



Second, a more macro-related factor could mean more capital is cycled into LSAK shares. Following South Africa&rsquo;s 2024 General Election, a coalition-style Government of National Unity is being formed. While <a href="https://www.reuters.com/markets/south-african-rand-weakens-focus-cabinet-announcement-2024-06-24/">uncertainty still looms</a>, if the current coalition holds, this should assuage worries about South Africa implementing fiscal policies that are less favorable to business and foreign investment. This could drive further interest in South African stocks. In turn, leading to a greater degree of discovery of LSAK by stateside investors.



<h2>Vaso (VASO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/healthcare1600a-300x169.jpg" alt="two doctors look over a piece of paper while standing in a hallway"><div>Source: Shutterstock</div></div>Vaso (OTCMKTS:<a href="https://investorplace.com/stock-quotes/vaso-stock-quote/">VASO</a>) is a medtech firm that provides a variety of products and services to the healthcare industry. Through its operating units, the company makes and sells medical equipment, as well as provides managed IT services to healthcare providers.



As an OTC-listed penny stock trading for well under $1 per share, VASO stock remains very much hidden from the radars of most investors. However, Vaso may not stay obscure forever. Why? While still pending, <a href="https://www.prnewswire.com/news-releases/vaso-corporation-a-diversified-medical-technology-company-currently-trading-on-the-otcqx-market-to-list-on-nasdaq-via-spac-merger-302009376.html">Vaso remains on track to be acquired</a> by Achari Ventures Holdings I (NASDAQ:<a href="https://investorplace.com/stock-quotes/avhi-stock-quote/">AVHI</a>), a special purpose acquisition company (SPAC).



Once this deal is completed, AVHI will take on the Vaso name. In effect, this deal serves a a de-facto uplisting for the company. It also provides an opportunity to shake off Vaso&rsquo;s penny stock reputation. Add in the potential to take AVHI&rsquo;s war chest of cash, and put it to work via acquisitions, and its easy to see how this could prove to be a successful SPAC transaction. With Vaso trading for only 12.8 times earnings, even a modest amount of multiple expansion could lead to big gains after the de-SPACing.



On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, Thomas Niel held ACTG and LSAK. He did not hold (either directly or indirectly) any positions in the other securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.
<div>Thomas Niel, contributor for InvestorPlace.com, has been writing single-stock analysis for web-based publications since 2016.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/06/treasure-hunt-7-penny-stocks-wall-street-hasnt-discovered-yet/">Treasure Hunt: 7 Penny Stocks Wall Street Hasn&#8217;t Discovered Yet</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Treasure Hunt: 7 Penny Stocks Wall Street Hasn't Discovered Yet

Vaso announces termination of business combination with Achari Ventures Holdings Corp. I

ACTG

AVHIU

AVHIW

BRFH

BUKS

ELTP

FTCO

HGBL

HROW

HROWL

HROWM

ISSC

LSAK

SGMA

Small Cap

Press Releases

Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger

Biotech

Health Care

Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2023

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Achari Ventures Holdings Corp. - AVHI

Management

StateHouse Reports First Quarter 2024, Fourth Quarter 2023, and Full Year 2023 Financial Results

Vaso Corporation Announces the Effectiveness of the Achari Ventures Holdings Corp. I Registration Statement on Form S-4

CSE:SLNG

CSE:STHZ

STHZF

Comments

Achari Ventures Holdings Corp I Ordinary Shares

Achari Ventures Holdings Corp I Ordinary Shares (AVHI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga